Morgan Stanley’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.25M | Sell |
|
|||||
|
2025
Q1 | $4.21M | Sell |
|
|||||
|
2024
Q4 | $6.42M | Buy |
|
|||||
|
2024
Q3 | $2.89M | Buy |
|
|||||
|
2024
Q2 | $2.81M | Sell |
|
|||||
|
2024
Q1 | $6.2M | Sell |
|
|||||
|
2023
Q4 | $17.1M | Buy |
|
|||||
|
2023
Q3 | $6.87M | Buy |
|
|||||
|
2023
Q2 | $6.57M | Sell |
|
|||||
|
2023
Q1 | $8.48M | Buy |
|
|||||
|
2022
Q4 | $5.79M | Buy |
|
|||||
|
2022
Q3 | $4.83M | Sell |
|
|||||
|
2022
Q2 | $7.35M | Buy |
|
|||||
|
2022
Q1 | $4.67M | Buy |
|
|||||
|
2021
Q4 | $4.54M | Buy |
|
|||||
|
2021
Q3 | $4.25M | Sell |
|
|||||
|
2021
Q2 | $9.93M | Buy |
|
|||||
|
2021
Q1 | $4M | Sell |
|
|||||
|
2020
Q4 | $11.8M | Buy |
|
|||||
|
2020
Q3 | $2.76M | Buy |
|
|||||
|
2020
Q2 | $2.35M | Sell |
|
|||||
|
2020
Q1 | $6.06M | Sell |
|
|||||
|
2019
Q4 | $9.9M | Buy |
|
|||||
|
2019
Q3 | $6.96M | Sell |
|
|||||
|
2019
Q2 | $8.55M | Sell |
|
|||||
|
2019
Q1 | $11.5M | Sell |
|
|||||
|
2018
Q4 | $17.3M | Buy |
|
|||||
|
2018
Q3 | $11.9M | Sell |
|
|||||
|
2018
Q2 | $21.9M | Sell |
|
|||||
|
2018
Q1 | $20.8M | Buy |
|
|||||
|
2017
Q4 | $15.9M | Sell |
|
|||||
|
2017
Q3 | $19.4M | Sell |
|
|||||
|
2017
Q2 | $19.3M | Sell |
|
|||||
|
2017
Q1 | $22.3M | Sell |
|
|||||
|
2016
Q4 | $28.5M | Sell |
|
|||||
|
2016
Q3 | $30.6M | Sell |
|
|||||
|
2016
Q2 | $21.2M | Buy |
|
|||||
|
2016
Q1 | $11.8M | Sell |
|
|||||
|
2015
Q4 | $13.4M | Sell |
|
|||||
|
2015
Q3 | $17.7M | Buy |
|
|||||
|
2015
Q2 | $18.5M | Buy |
|
|||||
|
2015
Q1 | $13.2M | Sell |
|
|||||
|
2014
Q4 | $20.9M | Buy |
|
|||||
|
2014
Q3 | $7.57M | Buy |
|
|||||
|
2014
Q2 | $11.2M | Buy |
|
|||||
|
2014
Q1 | $6M | Buy |
|
|||||
|
2013
Q4 | $4.01M | Buy |
|
|||||
|
2013
Q3 | $1.8M | Buy |
|
|||||
|
2013
Q2 | $250K | Buy |
|